LoadingUngerecht Joshua reported Grant or award in ExchangeRight Income Fund: 16347.2675 units of NLP 53 Common Units (derivative), dated 2026-10-06. The full Form 4 contains 2 transaction entries.
Thomas Warren reported Grant or award in ExchangeRight Income Fund: 16596.3702 units of NLP 53 Common Units (derivative), dated 2026-10-06. The full Form 4 contains 1 transaction entry.
TRXB
Coy Travis Alan reported Grant or award in TRex Bio, Inc.: 17500 units of Stock Option (Right to Buy) (derivative), dated 2026-10-08. The full Form 4 contains 1 transaction entry.
Booth Richard Whitaker reported Purchase in Fundrise Real Estate Interval Fund, LLC: 41.7362 units of Common Shares, dated 2026-10-07. The full Form 4 contains 1 transaction entry.
RTSN
BERGER FRANKLIN M reported Grant or award in Retension Pharmaceuticals, Inc.: 5636 units of Stock Option (right to buy) (derivative), dated 2026-10-08. The full Form 4 contains 1 transaction entry.
RTSN
BERENDT MICHAEL J reported Grant or award in Retension Pharmaceuticals, Inc.: 5636 units of Stock Option (right to buy) (derivative), dated 2026-10-08. The full Form 4 contains 1 transaction entry.
BLFS
Werner Sean reported Grant or award in BIOLIFE SOLUTIONS INC: 45838 units of Common Stock, dated 2026-10-06. The full Form 4 contains 4 transaction entries.
BLFS
Berard Todd reported Grant or award in BIOLIFE SOLUTIONS INC: 38198 units of Common Stock, dated 2026-10-06. The full Form 4 contains 4 transaction entries.
BLFS
Mathew Aby J. reported Grant or award in BIOLIFE SOLUTIONS INC: 45838 units of Common Stock, dated 2026-10-06. The full Form 4 contains 4 transaction entries.
BLFS
MOORE TIMOTHY L. reported Disposition to issuer in BIOLIFE SOLUTIONS INC: 44943 units of Common Stock, dated 2026-10-06. The full Form 4 contains 1 transaction entry.
BLFS
Hunt Anthony reported Disposition to issuer in BIOLIFE SOLUTIONS INC: 15046 units of Common Stock, dated 2026-10-06. The full Form 4 contains 1 transaction entry.
BLFS
DE GREEF RODERICK reported Grant or award in BIOLIFE SOLUTIONS INC: 225670 units of Common Stock, dated 2026-10-06. The full Form 4 contains 4 transaction entries.
BLFS
Coste Catherine reported Disposition to issuer in BIOLIFE SOLUTIONS INC: 13871 units of Common Stock, dated 2026-10-06. The full Form 4 contains 1 transaction entry.
BLFS
DuRoss Amy reported Disposition to issuer in BIOLIFE SOLUTIONS INC: 26857 units of Common Stock, dated 2026-10-06. The full Form 4 contains 1 transaction entry.
BLFS
Ellingson Rachel reported Disposition to issuer in BIOLIFE SOLUTIONS INC: 57995 units of Common Stock, dated 2026-10-06. The full Form 4 contains 1 transaction entry.
BLFS
GOSWAMI JOYDEEP reported Disposition to issuer in BIOLIFE SOLUTIONS INC: 53156 units of Common Stock, dated 2026-10-06. The full Form 4 contains 1 transaction entry.
BLFS
Wichterman Troy reported Grant or award in BIOLIFE SOLUTIONS INC: 76204 units of Common Stock, dated 2026-10-06. The full Form 4 contains 4 transaction entries.
TMS
Fishman Adam J reported 14,000 shares of Common Stock in Teamshares Inc as grants or awards dated 2026-09-29. The Form 4 was disclosed on Oct 9, 2026. These were stock awards, not open-market purchases.
OWLT
Workman Kurt reported Tax/exercise withholding in Owlet, Inc.: 20400 units of Common Stock, dated 2026-10-06. The full Form 4 contains 1 transaction entry.
TMS
Moore Evan Charles reported 14,000 shares of Common Stock in Teamshares Inc as grants or awards dated 2026-09-29. The Form 4 was disclosed on Oct 9, 2026. These were stock awards, not open-market purchases.
ASAN
Le Heather Tram reported 106,838 shares of Class A Common Stock in Asana, Inc. as grants or awards dated 2026-10-05. The Form 4 was disclosed on Oct 9, 2026. These were stock awards, not open-market purchases.
DBHL
Nelson Joseph Eugene reported Grant or award in Deep Isolation Nuclear, Inc.: 3577 units of Common Stock, dated 2026-10-06. The full Form 4 contains 2 transaction entries.
DBHL
Muller Elizabeth reported 23,214 shares of Common Stock in Deep Isolation Nuclear, Inc. as grants or awards dated 2026-10-06. The Form 4 was disclosed on Oct 9, 2026. These were stock awards, not open-market purchases.
DBHL
Airhart Steven reported Grant or award in Deep Isolation Nuclear, Inc.: 20000 units of Common Stock, dated 2026-10-06. The full Form 4 contains 2 transaction entries.
